Inclusion Criteria:
  1. All the cases with the primary diagnosis of acute or chronic synthetic cannabinoids toxicity will be included in the study.
  2. Willing and able to comply with the study procedures and provide written informed consent to participate in the study.
Exclusion Criteria:
  -  1- Patients with a history of any chronic disease (renal and hepatic). 2- Patients refuse to participate in the study. 3- Abuse to other drugs.